BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sartorius Corporation Appoints International Life Sciences Leader, Dominique Baly to its Top Management Team


1/3/2011 10:50:27 AM

Goettingen, Germany, January 3, 2011 / b3c newswire / – Effective January 1, 2011, the former Millipore executive, Dominique Baly, has assumed cross-divisional management of marketing, sales and service for the Sartorius laboratory business as President of Sartorius Group Laboratory Business. In this newly created position, he reports to the CEO and is a member of the Group Executive Committee. Sartorius Group highest-level management team is now composed of six individuals, including the Executives of both Sartorius AG and the subgroup Sartorius Stedim Biotech.

For the Sartorius Group, the new management appointment is a key component in the further strategic and operational development of its laboratory business. With the Bioprocess business significant rise in revenue and profit over the past years, the Executive Board is now increasing focus on the laboratory activities of both Group divisions. The major goals of this initiative are the expansion into strategic, fast growing market segments, the targeted extension of the product portfolio and the reinforcement of direct sales organizations in key markets.

“With Dominique Baly, we are gaining an exceptionally experienced and successful manager for our team. He will give our laboratory business decisive momentum in this fast-evolving market environment to define the future positioning for significant growth,” said CEO and Executive Board Chairman Dr. Joachim Kreuzburg.

“A strong brand, innovative technologies, a dedicated team and uncompromisingly high quality standards all come together at Sartorius. My goal is to leverage all of the above to build a leading laboratory instruments and consumable business across the world,” commented Dominique Baly on his new role at Sartorius.

Dominique Baly is a successful manager in the international laboratory business. He joins Sartorius with more than 35 years of sales and managerial experience for the U.S.-based pharmaceutical supplier Millipore Corporation, which was acquired by Merck KGaA in 2010. From 2005 to 2008, he was President of the $700 millions Bioscience Division. In 2009, he became CEO of Accelerator Sciences LLC, a U.S. investment firm backed by private equity. Baly is of dual nationality, French and American, holds a degree as a pharmacist from the Louis Pasteur University in Strasbourg (France) and has lived and worked in Europe, Asia and the United States of America.

This press release contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties.

This is a translation of the original German-language press release. Sartorius shall not assume any liability for the correctness of this translation. The original German press release is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected.

About Sartorius - www.sartorius.com

The Sartorius Group is a leading international laboratory and process technology provider covering the segments of biotechnology and mechatronics. In 2009, the technology group earned sales revenue of 602.1 million euros. Founded in 1870, the Goettingen-based company currently employs approximately 4,350 persons. The major areas of activity in its biotechnology segment focus on filtration, fluid management, fermentation, purification and laboratory applications. In the mechatronics segment, the company primarily manufactures equipment and systems featuring weighing, measurement and automation technology for laboratory and industrial applications. Key Sartorius customers are from the pharmaceutical, chemical and food and beverage industries and from numerous research and educational institutes of the public sector. Sartorius has its own production facilities in Europe, Asia and America as well as sales subsidiaries and local commercial agencies in more than 110 countries.

Contact

Petra Kirchhoff, Vice President of Group Corporate Communications

Sartorius Corporate Administration GmbH; 37070 Göttingen, Germany

Phone: +49 (0)551/ 308-1686; fax: +49 (0)551/ 308-3572

E-mail: petra.kirchhoff@sartorius.com; www.sartorius.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES